DOI: http://dx.doi.org/10.18203/2349-3259.ijct20161412

Quality management in risk based monitoring

Veerabhadra Sanekal Nayak, Mohammed Saleem Khan, Bharat Kumar S Shukla

Abstract


The essential thought of risk based quality administration is the recognizable proof of risks on a ceaseless premise for risk bearing exercises all through the configuration, behaviour, assessment and reporting of clinical trials. The procedure ought to begin at the season of convention outline so moderation can be incorporated with the convention and other trial related archives. Clinical Research is about creating information to bolster choices for creating and changing medicinal items and rehearses while ensuring the security, rights, prosperity of taking part subjects are ensured and coming about information are dependable. Choice making must be in the same class as the procedures used to deal with the clinical trials. Scholastic and industry driven clinical exploration is gradually adjusting quality danger administration forms for ahead of schedule recognizable proof of components with potential to influence subject wellbeing and convention consistence; preparing for those leading, directing and observing the study; ceaseless re-evaluation of needs; and corrective and preventive action (CAPA). Flawless control of exercises is once in a while conceivable to accomplish, yet a quality controlled and organized danger based methodology can be next best to flawlessness.


Keywords


Risk based monitoring, Quality management, Clinical trials, Triggers, Key risk indicators, Risk analysis, Quality, Static risk, Dynamic risk, Fixed risk, Risk review, Risk acceptance, Risk communication, Risk control

Full Text:

PDF

References


Djali S, Janssens S. How a data-driven quality management system. Drug Info. 2010;4:359-73.

Quality Assurance and Educational Standards for Clinical Trial Sites. J Oncol Pract. 2008;4(6):280-2.

Food and Drug Administration. Guidance for industry oversight of clinical investigations-a risk-based approach to monitoring. Available at http://www.fda.gov/downloads/Drugs/.../Guidances/UCM269919.pdf. Accessed 22nd February 2016.

PWC. Risk-based monitoring reduce clinical trial costs while protecting safety and quality.Available at http:// www.pwc.com / us / en / health –industries /publications/pharmaceutical-development-risk-based-monitoring.html. Accessed 22nd February 2016.

TDR News. Research needs quality management system. Available at http:// www.therqa.com/ assets / js / tiny _ mce / plugins / filemanager / files / Committees / Quality / Research _ needs _ quality _ managemeny _ system.pdf. Accessed 22nd February 2016.

Food and drug administration. Guidance for industry: Q9 quality risk management, 2006. Available at http:// www.fda.gov / downloads / Drugs / ... / Guidances / ucm073511.pdf. Accessed 22nd February 2016.

Food and drug administration. Office of regulatory affairs. Ora quality manual, 2012. Available at http://www.fda.gov/downloads/aboutfda/centersoffices/ora/ucm136320.pdf. Accessed 22nd February 2016.

Food and drug administration. Building quality into clinical trials- an FDA perspective, May 14, 2012. Available at http:// www.fda.gov / downloads / Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/UCM303954.pdf. Accessed 22nd February 2016.

Johnson, Jophy, Gupta, Vishal N. Recent advances in quality management of clinical trials. Int J Pharm Pharm Sci. 2013;5(3):34-8.

Clinical trials transformation initiative. Developing effective quality systems in clinical trials: an enlightened approach, 2010. Available at http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/UCM303954.pdf. Accessed 22nd February 2016.

Oleson, Wong K, Fay, Furay M. Application and key concepts for quality risk management in medical device clinical trials. Monitor, Asso Clinic Research Proff.2013;27:19-24.

Brosteanu O, Houben P, Ihrig K, Ohmann C, Paulus U, Pfistner B, Schwarz G, Strenge HA, Zettelmeyer U. Risk analysis and risk adapted on-site monitoring in non-commercial clinical trials. Clin Trials. 2009;6(6):585-96..

Bhatt A. Quality of clinical trials: A moving target. perceptive in clinical research perspect. Clin Res. 2011; 2(4):124-8.

American Society for Quality. Plan-Do-Check-Act (PDCA) Cycle. Available at http://asq.org/learn-about-quality/project-planning-tools/overview/pdca-cycle.html. Accessed 22nd February 2016.

European Medical Agency. ICH guideline Q10 on pharmaceutical quality system, 2015. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002871.pdf. Accessed 22nd February 2016.